Counterpoint Mutual Funds LLC Acquires New Shares in Aveanna Healthcare Holdings Inc. $AVAH

Counterpoint Mutual Funds LLC bought a new position in shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 321,757 shares of the company’s stock, valued at approximately $2,854,000. Aveanna Healthcare makes up 0.2% of Counterpoint Mutual Funds LLC’s portfolio, making the stock its 20th largest position.

Other large investors have also recently made changes to their positions in the company. AQR Capital Management LLC raised its stake in shares of Aveanna Healthcare by 21.2% during the 1st quarter. AQR Capital Management LLC now owns 26,280 shares of the company’s stock valued at $142,000 after purchasing an additional 4,602 shares during the period. Goldman Sachs Group Inc. grew its holdings in Aveanna Healthcare by 8.3% during the 1st quarter. Goldman Sachs Group Inc. now owns 339,853 shares of the company’s stock valued at $1,842,000 after buying an additional 25,974 shares in the last quarter. Jane Street Group LLC increased its position in shares of Aveanna Healthcare by 522.0% during the first quarter. Jane Street Group LLC now owns 75,081 shares of the company’s stock valued at $407,000 after buying an additional 63,010 shares during the period. MQS Management LLC bought a new stake in shares of Aveanna Healthcare during the second quarter valued at about $59,000. Finally, Belvedere Trading LLC purchased a new stake in shares of Aveanna Healthcare in the second quarter worth about $62,000. 87.96% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

AVAH has been the topic of a number of analyst reports. William Blair assumed coverage on shares of Aveanna Healthcare in a report on Monday, December 8th. They set an “outperform” rating on the stock. Truist Financial boosted their price target on shares of Aveanna Healthcare from $9.50 to $10.00 and gave the company a “hold” rating in a research report on Friday, November 7th. UBS Group increased their price objective on Aveanna Healthcare from $9.50 to $10.00 and gave the stock a “neutral” rating in a research report on Thursday, January 15th. Weiss Ratings reissued a “hold (c+)” rating on shares of Aveanna Healthcare in a research note on Monday, December 29th. Finally, Royal Bank Of Canada upped their target price on Aveanna Healthcare from $10.00 to $11.00 and gave the stock a “sector perform” rating in a research note on Thursday, January 15th. Five analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $11.06.

Aveanna Healthcare Price Performance

Shares of Aveanna Healthcare stock opened at $7.20 on Tuesday. The firm has a market capitalization of $1.50 billion, a PE ratio of 20.00 and a beta of 2.06. The company has a current ratio of 1.23, a quick ratio of 1.23 and a debt-to-equity ratio of 140.39. Aveanna Healthcare Holdings Inc. has a 12 month low of $3.67 and a 12 month high of $10.32. The business’s 50-day moving average price is $8.42 and its 200-day moving average price is $8.54.

Insider Buying and Selling at Aveanna Healthcare

In related news, insider Edwin C. Reisz sold 60,769 shares of the stock in a transaction on Thursday, February 19th. The shares were sold at an average price of $7.21, for a total transaction of $438,144.49. Following the transaction, the insider owned 1,447,057 shares of the company’s stock, valued at approximately $10,433,280.97. This trade represents a 4.03% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Jeff Shaner sold 173,225 shares of Aveanna Healthcare stock in a transaction on Thursday, February 19th. The stock was sold at an average price of $7.21, for a total transaction of $1,248,952.25. Following the completion of the transaction, the chief executive officer owned 2,650,892 shares in the company, valued at approximately $19,112,931.32. The trade was a 6.13% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 998,595 shares of company stock worth $7,567,770 over the last ninety days. Insiders own 7.00% of the company’s stock.

Aveanna Healthcare Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.